Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Shares Outstanding of 122.51 million shares for fiscal year 2025.
CATALYST PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 122.51M | +1.4% |
| 2024 | 120.88M | +12.8% |
| 2023 | 107.12M | +1.8% |
| 2022 | 105.26M | +2.2% |
| 2021 | 102.99M | -0.8% |
| 2020 | 103.78M | +0.4% |
| 2019 | 103.40M | +0.6% |
| 2018 | 102.74M | +0.2% |
| 2017 | 102.55M | +23.6% |
| 2016 | 82.97M | +0.1% |
| 2015 | 82.85M | +19.9% |
| 2014 | 69.12M | +27.7% |
| 2013 | 54.13M | +30.7% |
| 2012 | 41.42M | +67.7% |
| 2011 | 24.70M | +27.4% |
| 2010 | 19.39M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 123.26M | +3.4% | +0.7% |
| June 30, 2025 | 122.39M | +3.3% | +0.3% |
| March 31, 2025 | 121.96M | +3.3% | +0.9% |
| December 31, 2024 | 120.88M | +12.8% | +1.4% |
| September 30, 2024 | 119.27M | +11.9% | +0.6% |
| June 30, 2024 | 118.52M | +11.3% | +0.4% |
| March 31, 2024 | 118.03M | +11.4% | +10.2% |
| December 31, 2023 | 107.12M | +1.8% | +0.5% |
- CATALYST PHARMACEUTICALS, INC. showed an increase of +1.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, CATALYST PHARMACEUTICALS, INC.’s shares outstanding has grown by 531.7% (from 19.39 million shares to 122.51 million shares).
- The most recent figure is from CATALYST PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: